Old Web
English
Sign In
Acemap
>
authorDetail
>
Alexander Bodelier
Alexander Bodelier
Diabetes mellitus
Internal medicine
Medicine
Inflammatory bowel disease
Anesthesia
2
Papers
40
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study
2019
Clinical Pharmacology & Therapeutics
Vince Biemans
Vince Biemans
C. Janneke van der Woude
Gerard Dijkstra
Andrea E. van der Meulen-de Jong
Bas Oldenburg
Nanne K.H. de Boer
Mark Löwenberg
Nidhi Srivastava
Alexander Bodelier
Rachel L. West
Jeroen M. Jansen
Annemarie C. de Vries
J Haans
Dirk J. de Jong
Marie J. Pierik
Frank Hoentjen
Show All
Source
Cite
Save
Citations (0)
Serum concentrations after switching from originator infliximab to the biosimilar CT-P13 in patients with quiescent inflammatory bowel disease (SECURE): an open-label, multicentre, phase 4 non-inferiority trial
2018
The Lancet Gastroenterology & Hepatology
Anne S. Strik
Wim van de Vrie
Joanne P J Bloemsaat-Minekus
Michael T. Nurmohamed
Peter Bossuyt
Alexander Bodelier
Theo Rispens
Yvonne Megen
Geert R. DHaens
Show All
Source
Cite
Save
Citations (40)
1
map